Medolac Laboratories is a Delaware corporation (Neolac Inc. dba Medolac) headquartered at Lake Oswego, Oregon in the Pacific Northwest of the United States. Our vision is to provide human milk based therapies to critically ill babies and children on a global basis by applying proprietary biopharmaceutical processing methods that preserve the immune components in human milk while providing the safest, highest quality human milk formulations available to babies in need.

Using processing methods developed over the past three years, Medolac is providing a range of new human milk fortifiers and other human milk-based products for use in clinical and post discharge settings.  Medolac products are formulated to meet nutritional targets for preterm babies, and packaged in a way to maximize the safe storage, preparation and clinical use of our products.   

At Medolac we are committed to only sourcing our products from milk banks that empower donors and promote their interests.   We are also proud to be the first company primarily focused on the use of human milk in clinical settings to develop a publicly available "Commitment to Responsible Conduct."

Please note that Medolac is in no way affiliated with the Neolac infant formula company based in The Netherlands.